===日本臨床検査医学会機関誌============================================================== Vol. 61 No. 7 2013 ■原著合成基質法とトロンビン生成試験による各種ヘパリン類の抗 Xa 活性の評価 ····································································鈴木明子・・・ 567 APTT 検査における検査試薬による実測値の違い ···············································田中紀子・・・ 576 司会のことば··············································································································安東由喜雄・・・ 583 日本糖尿病学会における HbA1c 国際標準化の展開 ·············································柏木厚 HbA1c の国際標準化の課題と日本における対応 ··················································雨宮伸・・・ 594 臨床検査現場における NGSP 値導入とその後 ······················································石橋みどり・・・ 602 健診における HbA1c 結果表記の対応について ·····················································青木芳和・・・ 607 HbA1c 測定における IFCC 値、NGSP 値、JDS 値の関係【抄録】 ····················梅本雅夫・・・ 612 ■第 59 回学術集会シンポジウム 3：HbA1cの国際標準化とその波紋典・・・ 585 International standardisation of Haemoglobin A1c based on a metrologically sound international reference procedure【抄録】 ························ W. Garry John・・・ 613 シンポジウム 15：腎機能検査，尿検査の臨床的意義と今後の展開司会のことば··············································································································宿谷賢一・・・ 614 尾勝・・・ 616 野友二・・・ 622 田恒腎機能評価法と CKD 重症度分類の新たな展開～CKD 診療ガイド 2012 も含めて～···································································堀尿検査を見直す－今，尿検査に診療が求めるもの，これから尿検査が提供すべきもの－ ··································································油蛋白尿／腎機能の臨床における意義高畠研究(住民コホート)を中心に ······································································今夫・・・ 629 保険収載された新規バイオマーカー尿中 L-FABP の臨床的有用性··············································································池森(上條)敦子・・・ 635 ■日本臨床検査医学会ニュース日本臨床検査医学会 2013 年度第 1 回臨床検査専門医・管理医審議会たより ······························ 641 ===The Official Journal of Japanese Society of Laboratory Medicine======================= Rinsho Byori Vol. 61 No. 7 2013 ■Original Assessment of Anti-Factor Xa Activity for Heparin and Related Products by Chromogenic Assays and Thrombin Generation Tests··········································· Akiko SUZUKI・・・ 567 Comparison of Heparin-Induced Prolongation of APTT in 12 Different Laboratories in Kyushu Area·························································Noriko TANAKA・・・ 576 ■The 59th National Congress Symposium 3： Chairmen’s Introductory Remarks····················································································Yukio ANDO・・・ 583 Development of the HbA1c International Standardization of HbA1c Measurement in Japan Diabetes Society······················································ Atsunori KASHIWAGI・・・ 585 The Worldwide Standardization of Hemoglobin A1c Measurement: The Current Statement from the Japan Diabetes Society and the Issues to Be Solved····························Shin AMEMIYA・・・ 594 Introduction of the NGSP Value in Clinical Practice and Later ··························· Midori ISHIBASHI・・・ 602 Approach to the Changes of HbA1c Notation in Health Checkups···························Yoshikazu AOKI・・・ 607 Abstract·························································································································································· 612 Abstract·························································································································································· 613 Symposium 15： Chairmen’s Introductory Remarks········································································ Kenichi SHUKUYA・・・ 614 Development of Evaluation of Kidney Function and Classification of Chronic Kidney Disease(CKD) －Including CKD Clinical Practice Guide 2012－ ·················································Masaru HORIO・・・ 616 A Review of Urinary Examination－What Medical Practice Expects Now and What Urinary Examinations Have to Provide in the Future－ ······························· Tomoji YUNO・・・ 622 Clinical Significance of Proteinuria and Renal Function: Findings from a Population-Based Cohort, the Takahata Study····························· Tsuneo KONTA・・・ 629 Urinary L-Type Fatty Acid Binding Protein(L-FABP) as a New Urinary Biomarker Promulgated by the Ministry of Health, Labour and Welfare in Japan ································································ Atsuko KAMIJO-IKEMORI・・・ 635 ■News JSLM NEWS ·················································································································································· 641